Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Pharmaceutical Companies in 2026
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2026, World Largest Pharmaceutical Companies by Market Cap in 2026.
  1. Sandoz Group AG

    World Rank (Aug-2026)
    661
    Market Cap (Aug-2026)
    39.923 Billion USD
    World Rank (Jan-05-2024)
    1,209
    Market Cap (Jan-05-2024)
    14.504 Billion USD
    Headquarters Country
    Stock Category
    Company Profile

    Switzerland based pharmaceutical company. Headquarters is in Switzerland.

  2. Otsuka Holdings

    World Rank (Aug-2026)
    662
    Market Cap (Aug-2026)
    39.862 Billion USD
    World Rank (Jan-05-2024)
    873
    Market Cap (Jan-05-2024)
    20.890 Billion USD
    World Rank (Jul-30-2023)
    891
    Market Cap (Jul-30-2023)
    20.707 Billion USD
    World Rank (Dec-25-2022)
    923
    Market Cap (Dec-25-2022)
    18.024 Billion USD
    World Rank (Jan-07-2022)
    1,039
    Market Cap (Jan-07-2022)
    19.94 Billion USD
    Annual Revenue in USD
    12,312 Million USD
    Annual Operating Income in USD
    1,318 Million USD
    Annual Net Income in USD
    949 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Otsuka Holdings is Pharmaceutical company with headquarters is in Japan.
  3. IQVIA Holdings

    World Rank (Aug-2026)
    676
    Market Cap (Aug-2026)
    38.954 Billion USD
    World Rank (Jan-05-2024)
    450
    Market Cap (Jan-05-2024)
    40.165 Billion USD
    World Rank (Jul-30-2023)
    435
    Market Cap (Jul-30-2023)
    41.962 Billion USD
    World Rank (Dec-25-2022)
    436
    Market Cap (Dec-25-2022)
    37.861 Billion USD
    World Rank (Jan-07-2022)
    396
    Market Cap (Jan-07-2022)
    49.08 Billion USD
    Annual Revenue in USD
    16,310 Million USD
    Annual Operating Income in USD
    2,182 Million USD
    Annual Net Income in USD
    1,360 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    IQVIA HOLDINGS provides Data, Clinical Trails Data, Information, Analytics and Technology to Healthcare Companies. Headquarters is in USA.IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry.

    Facts About Company

    IQVIA HOLDINGS annual revenue generated for period ending Dec-2022 was 14,410 million USD.

    IQVIA HOLDINGS annual net income generated for period ending Dec-2022 was 1,091 million USD.

  4. Royalty Pharma PLC

    World Rank (Aug-2026)
    783
    Market Cap (Aug-2026)
    33.695 Billion USD
    World Rank (Jan-05-2024)
    1,072
    Market Cap (Jan-05-2024)
    16.638 Billion USD
    World Rank (Jul-30-2023)
    1,273
    Market Cap (Jul-30-2023)
    13.997 Billion USD
    World Rank (Dec-25-2022)
    960
    Market Cap (Dec-25-2022)
    17.397 Billion USD
    World Rank (Jan-07-2022)
    1,178
    Market Cap (Jan-07-2022)
    17.29 Billion USD
    Annual Revenue in USD
    2,378 Million USD
    Annual Operating Income in USD
    1,560 Million USD
    Annual Net Income in USD
    771 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Royalty Pharma is the leader in acquiring Pharmaceutical company royalties across the life sciences industry. The headquarters is in USA.

    Royalty Pharma plc is a funder of biopharmaceutical industry.The company includes royalties on commercial products.

    It is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.

    As on 2019, Royalty Pharma has 35 employees.

  5. Celltrion

    World Rank (Aug-2026)
    794
    Market Cap (Aug-2026)
    33.137 Billion USD
    World Rank (Jan-05-2024)
    509
    Market Cap (Jan-05-2024)
    35.824 Billion USD
    World Rank (Jul-30-2023)
    1,134
    Market Cap (Jul-30-2023)
    16.020 Billion USD
    World Rank (Dec-25-2022)
    883
    Market Cap (Dec-25-2022)
    18.618 Billion USD
    World Rank (Jan-07-2022)
    985
    Market Cap (Jan-07-2022)
    21.21 Billion USD
    Annual Revenue in USD
    1,793 Million USD
    Annual Operating Income in USD
    508 Million USD
    Annual Net Income in USD
    422 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Celltrion is a Biopharmaceutical company. The headquarters is in South Korea.

    Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.

  6. Horizon Therapeutics Public Company

    World Rank (Aug-2026)
    819
    World Rank (Jan-05-2024)
    819
    World Rank (Jul-30-2023)
    819
    Market Cap (Jul-30-2023)
    22.879 Billion USD
    World Rank (Dec-25-2022)
    660
    Market Cap (Dec-25-2022)
    25.647 Billion USD
    World Rank (Jan-07-2022)
    940
    Market Cap (Jan-07-2022)
    22.27 Billion USD
    Annual Revenue in USD
    3,629 Million USD
    Annual Operating Income in USD
    729 Million USD
    Annual Net Income in USD
    521 Million USD
    Annual Results for Period Ending
    Jun-2022 ending year
    Headquarters Country
    Company Profile

    Horizon Therapeutics is a Pharmaceutical company with headquarters is in Ireland.

    Amgen acquired Horizon Therapeutics for 27.8 billion USD in Oct-2023.

  7. Daiichi Sankyo Company

    World Rank (Aug-2026)
    835
    Market Cap (Aug-2026)
    31.322 Billion USD
    World Rank (Jan-05-2024)
    329
    Market Cap (Jan-05-2024)
    53.253 Billion USD
    World Rank (Jul-30-2023)
    306
    Market Cap (Jul-30-2023)
    55.893 Billion USD
    World Rank (Dec-25-2022)
    231
    Market Cap (Dec-25-2022)
    61.852 Billion USD
    World Rank (Jan-07-2022)
    499
    Market Cap (Jan-07-2022)
    40.77 Billion USD
    Annual Revenue in USD
    9,057 Million USD
    Annual Operating Income in USD
    854 Million USD
    Annual Net Income in USD
    773 Million USD
    Annual Results for Period Ending
    Mar-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    DAIICHI SANKYO COMPANY is Pharmaceutical and Medical equipment manufacturing company with headquarters is in Tokyo, Japan.

  8. Biogen

    World Rank (Aug-2026)
    844
    Market Cap (Aug-2026)
    31.003 Billion USD
    World Rank (Jan-05-2024)
    473
    Market Cap (Jan-05-2024)
    38.171 Billion USD
    World Rank (Jul-30-2023)
    470
    Market Cap (Jul-30-2023)
    38.390 Billion USD
    World Rank (Dec-25-2022)
    405
    Market Cap (Dec-25-2022)
    40.199 Billion USD
    World Rank (Jan-07-2022)
    609
    Market Cap (Jan-07-2022)
    34.17 Billion USD
    Annual Revenue in USD
    9,891 Million USD
    Annual Net Income in USD
    1,293 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    Biogen INC is USA based Bio-Technology Company and they are pioneers in neuroscience medical science. Headquarters is in Massachusetts, USA.

  9. Alnylam Pharmaceuticals

    World Rank (Aug-2026)
    855
    Market Cap (Aug-2026)
    30.595 Billion USD
    World Rank (Jan-05-2024)
    763
    Market Cap (Jan-05-2024)
    24.134 Billion USD
    World Rank (Jul-30-2023)
    762
    Market Cap (Jul-30-2023)
    24.817 Billion USD
    World Rank (Dec-25-2022)
    578
    Market Cap (Dec-25-2022)
    29.268 Billion USD
    World Rank (Jan-07-2022)
    1,156
    Market Cap (Jan-07-2022)
    17.72 Billion USD
    Annual Revenue in USD
    3,714 Million USD
    Annual Operating Income in USD
    502 Million USD
    Annual Net Income in USD
    314 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    ALNYLAM PHARMACEUTICALS is Biopharmaceutical company with headquarters is in Massachusetts, USA.ALNYLAM leaders from the biopharmaceutical industry, bringing together their experiences of drug discovery, drug development, and commercialization.Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines.

  10. Zoetis

    World Rank (Aug-2026)
    858
    Market Cap (Aug-2026)
    30.492 Billion USD
    World Rank (Jan-05-2024)
    168
    Market Cap (Jan-05-2024)
    89.086 Billion USD
    World Rank (Jul-30-2023)
    164
    Market Cap (Jul-30-2023)
    87.755 Billion USD
    World Rank (Dec-25-2022)
    202
    Market Cap (Dec-25-2022)
    67.935 Billion USD
    World Rank (Jan-07-2022)
    156
    Market Cap (Jan-07-2022)
    99.87 Billion USD
    Annual Revenue in USD
    9,467 Million USD
    Annual Operating Income in USD
    3,546 Million USD
    Annual Net Income in USD
    2,673 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Zoetis is a Pharmaceutical company manufacturing medicine and vaccinations for animals. Headquarters is in USA. As on 2021, Zoetis have over 12,100 employees. Zoetis headquarters is in USA.

    As on 2022, Zoetis has 13,800 employees.

    Zoetis annual revenue generated for period ending Dec-2022 was 8,080 million USD.

    Zoetis annual net income generated for period ending Dec-2022 was 2,114 million USD.

Share

Ads